← The Wire
OGNNYSE
Organon & Co.
Pharmaceutical Preparations · CIK 1821825
Organon & Co. develops, manufactures, and markets women's health products, biosimilars, and established medicines
red 8-K · 90d
$3.53B
Market cap
$13.55
Last close
+0.4%
1D
+1.1%
5D
1.4M
Volume
Price · last 39 sessions+2.2%
May 4L $13.26 · H $13.55Jun 29
90
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 11, 2026DEFA14ADEFA14AJun 11, 202610-Q10-QMay 4, 2026DEFA14ADEFA14AApr 30, 2026DEFA14ADEFA14AApr 30, 20268-KResults of OperationsApr 30, 2026DEFA14ADEFA14AApr 27, 2026DEFA14ADEFA14AApr 27, 2026DEFA14ADEFA14AApr 27, 2026DEFA14ADEFA14AApr 27, 20268-KExecutive Change · Material AgreementApr 27, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 202610-K10-KFeb 24, 20268-KCompany UpdateFeb 20, 20268-KResults of Operations · Reg FD DisclosureFeb 12, 202610-Q10-QNov 10, 20258-KResults of Operations · Reg FD DisclosureNov 10, 202510-Q/A10-Q/ANov 10, 202510-Q/A10-Q/ANov 10, 202510-K/A10-K/ANov 10, 20258-KExecutive ChangeNov 7, 20258-K/AExecutive ChangeOct 30, 20258-KExecutive Change · Company UpdateOct 27, 202510-Q10-QAug 6, 20258-KResults of Operations · Reg FD DisclosureAug 5, 20258-KExecutive Change · Shareholder VoteJun 12, 20258-KCompany UpdateMay 27, 202510-Q10-QMay 2, 20258-KResults of Operations · Reg FD DisclosureMay 1, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 20258-KExecutive Change · Reg FD DisclosureApr 15, 202510-K10-KFeb 28, 20258-KResults of Operations · Reg FD DisclosureFeb 13, 20258-KExecutive ChangeJan 21, 20258-KCompany UpdateDec 23, 20248-KExecutive ChangeDec 6, 20248-KReg FD DisclosureNov 5, 202410-Q10-QNov 1, 20248-KResults of Operations · Reg FD DisclosureOct 31, 20248-KMaterial AgreementSep 23, 202410-Q10-QAug 7, 20248-KResults of Operations · Reg FD DisclosureAug 6, 20248-KShareholder VoteJun 6, 20248-KMaterial Agreement · New Debt / ObligationMay 17, 202410-Q10-QMay 3, 20248-KResults of Operations · Reg FD DisclosureMay 2, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 202410-K10-KFeb 26, 20248-KResults of Operations · Reg FD DisclosureFeb 15, 20248-KExecutive ChangeDec 5, 202310-Q10-QNov 3, 20238-KResults of Operations · Reg FD DisclosureNov 2, 202310-Q10-QAug 9, 20238-KResults of Operations · Reg FD DisclosureAug 8, 20238-KMaterial Agreement · New Debt / ObligationJul 7, 20238-KShareholder VoteJun 8, 202310-Q10-QMay 5, 20238-KResults of Operations · Reg FD DisclosureMay 4, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 27, 202310-K10-KFeb 27, 20238-KResults of Operations · Reg FD DisclosureFeb 16, 2023SC 13GSCHEDULE 13GFeb 13, 2023SC 13GSC 13GFeb 10, 20238-KSecurity-Holder Rights · Bylaw AmendmentDec 9, 202210-Q10-QNov 4, 20228-KResults of Operations · Reg FD DisclosureNov 3, 202210-Q10-QAug 5, 20228-KResults of Operations · Reg FD DisclosureAug 4, 20228-KExecutive ChangeJul 12, 20228-KShareholder VoteJun 8, 20228-KReg FD DisclosureMay 6, 202210-Q10-QMay 6, 20228-KResults of Operations · Reg FD DisclosureMay 5, 2022DEFA14ADEFA14AApr 29, 2022DEF 14ADEF 14AApr 28, 202210-K10-KMar 21, 2022
Insider Activity
In the 90 days to Nov 12, 2025: 1 insider bought $502K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 12, 2025 | Cox Carrie SmithExecutive Chair | Buy | 65,400 | $7.67 | $502K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance